Multi-component plasma quantitation of anti-hyperglycemic pharmaceutical compounds using liquid chromatography-tandem mass spectrometry

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 856, Issue 1-2, 2007, Pages 318-327

  Wang, Ming ^a   Miksa, Irina R ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Analytical; Chemistry; Chromatography; Drugs; GLP; Hypoglycemic; Mass spectrometry

Indexed keywords

DISEASE CONTROL; GLUCOSE; INSULIN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PLASMA (HUMAN);

BIOANALYTICAL METHODS; BLOOD GLUCOSE LEVELS; HYPOGLYCEMIC AGENTS;

DRUG PRODUCTS;

ACETONITRILE; AMMONIUM FORMATE; ANTIDIABETIC AGENT; FORMIC ACID; GLIBENCLAMIDE; GLIPIZIDE; METFORMIN; NATEGLINIDE; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE;

ACCURACY; ARTICLE; AUTOMATION; DILUTION; DRUG BLOOD LEVEL; DRUG STABILITY; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; PRECIPITATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; TANDEM MASS SPECTROMETRY;

CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; HYPOGLYCEMIC AGENTS; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

EID: 34548119793     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2007.06.037     Document Type: Article

References (32)

1. Valsamakis G., and Kumar S. Expert Opin. Pharmacother. 1 (2000) 1413
2. Wu C.L., Lee L.H., Lee B.R., and Lee C.-J. Clin. Trials Drugs Biopharm. (2006) 363
3. Horton E.S., Clinkingbeard C., Gatlin M., Foley J., Mallows S., and Shen S. Diab. Care 23 (2000) 1660
4. Hirschberg Y., Karara A.H., Pietri A.O., and McLeod J.E. Diab. Care 23 (2000) 349
5. Rendell M.S., Glazer N.B., and Ye Z. J. Diab. Complications 17 (2003) 211
6. Riddle M. Am. J. Med. 108 (2000) 15S
7. Dailey G.E. Expert Opin. Pharmacother. 4 (2003) 1417
8. Bruce S., Park J.-S., Fiedorek F.T., and Howlett H.C.S. Int. J. Clin. Practice 60 (2006) 783
9. Davidson J.A., Scheen S.J., Howlett H.C.S., and Harry C.S. Drug Safety 27 (2004) 1205
10. Bailey C.J., and Day C. Int. J. Clin. Practice 58 (2004) 867
11. Nakamoto M. Diab. Self-Manage. 20 (2003) 14
12. The Medical Letter on Drugs and Therapeutics 44 (2002) 107-109.
13. Musselman R.C. Home Care Provider 3 (1998) 95
14. Ramsdell J.W., Braunstein S.N., Stephens J.M., Bell C.F., Botteman M.F., and Devine S.T. PharmacoEconomics 21 (2003) 819
15. Kabadi U.M., and Kabadi M.M. Compr. Ther. 21 (1995) 731
16. Chou C.-C., Lee M.-R., Cheng F.-C., and Yang D.-Y. J. Chromatogr. A 1097 (2005) 74
17. David V., Barcutean C., Sora I., and Medvedovici A. Revue Roumaine de Chimie 50 (2005) 269
18. AbuRuz S., Millership J., and McElnay J. J. Chromatogr. B 832 (2006) 202
19. Koseki N., Kawashita H., Miyuki N., Nagae Y., and Masuda N. J. Pharm. Biomed. Anal. 36 (2005) 1063
20. Wang Y., Tang Y., Gu J., Fawcett J.P., and Bai X. J. Chromatogr. B 808 (2004) 215
21. Heinig K., and Bucheli F. J. Pharm. Biomed. Anal. 34 (2004) 1005
22. Chen B.-M., Liang Y.-Z., Guo F.-Q., Huang L.-F., Deng F.-L., Chen X., and Wang Y.-L. Anal. Chim. Acta 514 (2004) 185
23. AbuRuz S., Millership J., and McElnay J. J. Chromatogr. B 817 (2005) 277
24. Kolte B.L., Raut B.B., Deo A.A., Bagool M.A., and Shinde D.B. J. Sep. Sci. 28 (2005) 2076
25. Zhong G.-P., Bi H.-C., Zhou S., Chen X., and Huang M. J. Mass Spectrom. 40 (2005) 1462
26. Hoizey G., Lamiable D., Trenque T., Robinet A., Binet L., Kaltenbach M.L., Havet S., and Millart H. Clin. Chem. 51 (2005) 1666
27. Lin Z.J., Desai-Krieger D., and Shum L. J. Chromatogr. B 801 (2004) 265
28. Ho E., Yiu K., Wan T., Stewart B.D., and Watkins K.L. J. Chromatogr. B 811 (2004) 65
29. Maurer H.H., Kratzsch C., Kraemer T., Peters F.T., and Weber A.A. J. Chromatogr. B 773 (2002) 63
30. Mueller C.A., Weinmann W., Dresen S., Schreiber A., and Gergov M. Rapid Commun. Mass Spec. 19 (2005) 1332
31. Zeng W., Fisher A.L., Musson D.G., and Wang A.Q. J. Chromatogr. B 806 (2004) 177
32. Jessome L.L., and Volmer D.A. LC-GC North Am. 24 (2006) 498